Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
about
CXCR2: a target for pancreatic cancer treatment?Antibodies trap tissue migrating helminth larvae and prevent tissue damage by driving IL-4Rα-independent alternative differentiation of macrophagesEpigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancerChemokines as mediators of tumor angiogenesis and neovascularizationOverexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.CXC chemokines in cancer angiogenesis and metastasesChemokines as therapeutic targets in renal cell carcinomaChemokines as mediators of neovascularizationOpposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.K-Ras promotes angiogenesis mediated by immortalized human pancreatic epithelial cells through mitogen-activated protein kinase signaling pathways.ELR+ CXC chemokine expression in benign and malignant colorectal conditionsExpression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue.Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.Roles of CXCL5 on migration and invasion of liver cancer cellsChemokines and angiogenesis in rheumatoid arthritis.The role of chemoattractant receptors in shaping the tumor microenvironment.Quantitative proteomic profiling studies of pancreatic cancer stem cellsNew insights in synovial angiogenesis.Angiogenesis in rheumatoid arthritis.Angiogenesis and its targeting in rheumatoid arthritisTargeting Angiogenesis in Rheumatoid ArthritisInterleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancerThe emerging role of CXC chemokines and their receptors in cancer.Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedbA combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis.Association between preeclampsia and the CXC chemokine family (Review).Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis.Role of chemokines in tumor growth.Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatmentAbrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.CXCR2 macromolecular complex in pancreatic cancer: a potential therapeutic target in tumor growthChemokines and squamous cancer of the head and neck: targets for therapeutic intervention?Silencing of CXCR2 and CXCR7 protects against esophageal cancerGender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.miR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma.Neutrophils: key mediators of tumour angiogenesis.CXCR2 in acute lung injury.Contribution of bone marrow derived cells to the pancreatic tumor microenvironment.
P2860
Q27021588-02D9E71A-B7DF-4583-8BC2-FF31C0609603Q27332024-21EF6C57-7A3F-4E18-9C76-210EE41E31B1Q28743229-ACF948D9-1E08-4FBB-828F-0F374442BE09Q30427886-C67C0B46-1A7E-412E-8BA3-4B914630FD60Q30427989-B404EF82-442A-41D6-BEAA-C18DFD22B630Q30432791-D20BF375-1A26-4816-B82D-B5285C9FABE5Q30435873-77C20888-29ED-49CA-8632-A6086DC2DBD3Q30438032-F691A58F-F979-4349-961B-FAC28B7F3F75Q30439835-C2B2E681-12FB-44AB-A92E-27713F6C1E30Q30608512-B006D810-981A-4C53-85DC-5490E0BC4C0CQ33346619-F89A91A2-3742-46D6-AC39-41B0615B8729Q33562569-F1A9F7A1-B33E-4B38-B6B7-5E137878307AQ33602017-3CB605A3-AF33-44F7-BEAA-614023A20525Q33897910-30457DB7-4EC3-4758-A3F5-65A6AF520B9BQ33909030-2D0EF3E3-E4D5-401C-8C7D-0ED3FA398950Q33993124-EA58FAD8-AF4F-4C13-BD8C-DE786D1F09A8Q34004256-0A07064F-F3FA-4E57-B286-31CB022A085BQ34022062-5DFC8732-40A4-4990-AD98-A5D017C14AF5Q34051829-32AF82B1-6FDA-4C56-A60B-03B915A83059Q34051950-E437B6F8-95EA-467D-B34A-B25ECCFF480FQ34058895-D935C128-BB62-4606-BF8A-FC1283E84933Q34091347-C1C57680-2F47-4016-AA7E-13391346546CQ34263645-B33169ED-87A1-4F66-9F55-CC5AD5B8ECE2Q34537320-C9239CCF-59F4-4ACF-AEFC-E4D5E3C4C992Q35498775-C92834E7-91E0-4D0B-8991-1A181A83FCCFQ35498810-F1A3B601-1A46-40AA-B9A7-6C8F1D020BBDQ35659991-FE9E6A35-F26C-455E-A5E9-BF691F32CFDDQ35753903-418236E1-2B62-4785-8C3E-6323BAC6EE0FQ35770942-872EB674-0CFE-4F42-960C-D2340373A643Q36120825-8723FCB3-36C9-4CD9-94D7-9C4008B6615BQ36150219-44C2D5DA-B95A-4369-ACF1-2A9BE6E0390BQ36464443-D01AF28B-B0AF-4584-8FFB-8844DCA89CB2Q36723785-B91883AA-8E84-4CE5-8959-DCF2B3E5F612Q36752040-8896EEB7-2A07-4C5F-A566-D2AFBCA8A33CQ37227971-D44E7C20-D3EF-455E-AD10-9C2EBD1CFD97Q37332789-273EF56B-AA15-41E0-BA93-F496B0FF560FQ37363612-C7352789-C74D-4144-9A17-46A4AAA8DF63Q37534968-98D94B1B-E41B-49F5-A8E6-FE13EE5D8C92Q38020471-2701BFBF-7C8F-4965-BDFE-A9FCA7AAC4A6Q38093364-6E6E6A26-0287-4C95-9789-406AF5A73457
P2860
Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Blockade of the chemokine rece ...... cer cell-induced angiogenesis.
@en
type
label
Blockade of the chemokine rece ...... cer cell-induced angiogenesis.
@en
prefLabel
Blockade of the chemokine rece ...... cer cell-induced angiogenesis.
@en
P2093
P50
P1433
P1476
Blockade of the chemokine rece ...... cer cell-induced angiogenesis.
@en
P2093
Howard A Reber
Marie D Burdick
Michael P Keane
Moritz N Wente
Oscar J Hines
Robert M Strieter
P304
P356
10.1016/J.CANLET.2005.10.041
P407
P577
2006-02-03T00:00:00Z